Evaluation of the antitumour activity of liposomal formulations of etoposide against choriocarcinoma xenografts in Balb/c nu/nu mice

Pharmacy and Pharmacology Communications

Volumn 5, Issue 10, 1999, Pages 595-598

  Tyagi, P ^a   Sengupta, S ^a   Velpandian, T ^a   Gupta, Y K ^a   Kochupillai, V ^b   Gupta, S K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CHORIOCARCINOMA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; ENCAPSULATION; FEMALE; LIPOPHILICITY; MOUSE; NONHUMAN; XENOGRAFT;

EID: 0032695907     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128734190     Document Type: Article

References (22)

1. Cammisuli, S., Winiski, A., Nussbaumer, P., Hiestand, P., Stutz, A., Weckbecker, G. (1996) SDZ 281-977: a modified partial structure of lavendustin A that exerts potent and selective antiproliferative activities in vitro and in vivo. Int. J. Cancer 65: 351-359
2. Chang, C. W., Barber, L., Ouyang, C., Masin, D., Bally, M. B., Madden, T. D. (1997) Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice. Br. J. Cancer 75: 169-177
3. Corbett, T. H., Roberts, B. J., Leopold, W. R., Peckham, J. C., Wilkoff, L. J., Griswold, D. P., Schabel, F. M. (1984) Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res. 44: 717-726
4. Gabizon, A., Papahadjopoulos, D. (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl Acad. Sci. USA 85: 6949-6953
5. Gabizon, A., Goren, D., Fuks, Z., Meshorer, A., Barenholz, Y. (1985) Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model. Br. J. Cancer 51: 681-689
6. Hande, K. R. (1992) Etoposide pharmacology. Semin. Oncol. 19 (Suppl. 13): 3-9
7. Hande, K. R. (1998) Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 34: 1514-1521
8. Harashima, H., Sakata, K., Funato, K., Kiwada, H. (1994) Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharm. Res. 11: 402-406
9. Huang, S. K., Mayhew, E., Gilani, S., Lasic, D. D., Martin, F. J., Papahadjopoulos, D. (1992) Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. 52: 6774-6781
10. Liliemark, E., Liliemark, J., Kallberg, N., Bjorkholm, M., Sjostrom, B., Peterson, C. (1995) Studies of the organ distribution in mice of teniposide liposomes designed for treatment of diseases in the mononuclear phagocytic system. Pediatr. Res. 38: 7-10
11. Mahato, R. I., Kawabata, K., Nomura, T., Takakura, Y., Hashida, M. (1995) Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J. Pharm. Sci. 84: 1267-1271
12. Nakata, H., Kikuchi, Y., Tode, T., Hirata, J., Kita, T., Ishii, K., Kudoh, K., Nagata, I., Shinomiya, N. (1998) Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn. J. Cancer Res. 89: 733-740
13. O'Dwyer, P. J., Weiss, R. B. (1984) Hypersensitivity reactions induced by etoposide. Cancer Treat. Rep. 68: 959-961
14. Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., Redemann, C., Martin, F. J. (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl Acad. Sci. USA 88: 11460-11464
15. Parker, S. E., Khatibi, S., Margalith, M., Anderson, D., Yankauckas, M., Gromkowski, S. H., Latimer, T., Lew, D., Marquet, M., Manthorpe, M., Hobart, P., Hersh, E., Stopeck, A. T., Norman, J. (1996) Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. Cancer Gene Ther. 3: 175-185
16. Pratt, G., Wiles, M. E., Rawstron, A. C., Davies, F. E., Fenton, J. A., Proffitt, J. A., Child, J. A., Smith, G. M., Morgan, G. J. (1998) Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma. Hematol. Oncol. 16: 47-55
17. Ranson, M. R., Carmichael, J., O'Byrne, K., Stewart, S., Smith, D., Howell, A. (1997) Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J. Clin. Oncol. 15: 3185-3191
18. Reimer, D. L., Kong, S., Monck, M., Wyles, J., Tam, P., Wasan, E. K., Bally, M. B. (1999) Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates. J. Pharmacol. Exp. Ther. 289: 807-815
19. Sengupta, S., Velpandian, T., Sapra, P., Sanyal, M., Gupta, S. K. (1998) Etoposide encapsulated long circulating liposomes: improved anti-tumour efficacy with reduced adverse effects. Naunyn Schmiedebergs Arch. Pharmacol. 358 (Suppl. 2): R531
20. Vaage, J., Donovan, D., Wipff, E., Abra, R., Colbern, G., Uster, P., Working, P. (1999) Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes. Int. J. Cancer 80: 134-137
21. Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., Jain, R. K. (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res. 54: 3352-3356
22. Zhu, N., Liggitt, D., Liu, Y., Debs, R. (1993) Systemic gene expression after intravenous DNA delivery into adult mice. Science 261: 209-211